Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO action...'148 Non final action mailed today in Transaction History eom

it looks like the examiner found another piece of prior art (Tanimura) that combined with Kagi and Baluga sp?? makes the 148 obvious to one skilled in the art............yadda yadda.

here we go again.

do you think Chuck Moore can persuade the examiner again, that Tanimura combined with the other prior art does not make the 148 "obvious"?

I look forward to hearing the responses of those with engineering backrounds/connections.

TIA

Deb



Share
New Message
Please login to post a reply